Fredrik Palm
CEO
Inify Laboratories
Inify Laboratories provides cancer diagnostics through a fully digital, standardized, and AI-supported workflow, specifically focusing on prostate pathology. The lab reduces turnaround times for biopsy results to five working days, enhancing the accuracy and consistency of cancer evaluations.
- Artificial Intelligence
- Data & Analytics
- Healthcare Technology
- Medical Devices
- Software Only
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Problem
Traditional pathology labs face increasing workloads and complexity in cancer diagnostics, leading to potential delays and variability in results. The subjective nature of cancer grading and staging can result in inconsistencies between pathologists, impacting diagnostic accuracy.
Solution
Inify Laboratories offers specialized cancer diagnostics through a fully digital, AI-supported workflow, initially focused on prostate pathology. By combining state-of-the-art AI, advanced lab equipment, and standardized processes, Inify aims to improve the quality, consistency, and turnaround time of cancer evaluations. The lab provides a complete diagnostic service, from sample preparation to reporting, with reports created by specialized uropathologists. Inify's streamlined processes and AI-driven decision support tools ensure high-quality, easily interpretable visual reports, enabling more informed treatment decisions.
Target Audience
Inify Laboratories primarily serves urologists and pathology departments seeking to enhance their diagnostic services with faster turnaround times, consistent quality, and AI-supported analysis.
Features
- Fully digital histopathology laboratory specializing in uropathology
- AI-powered diagnostic decision support tools for accurate and efficient analysis
- Standardized workflow from sample preparation to reporting, ensuring consistent quality
- Visual reports designed in collaboration with urologists for easy interpretation
- Short turnaround times, delivering pathology reports within five working days
- Traceable logistics with efficient biopsy specimen transport
- Advanced image quality to minimize variations in diagnosis